Liao DY - Search Results

1

Ferroptosis in renal fibrosis: a mini-review.

Yang SQ, Zhao X, Zhang J, Liao DY, Wang YH, Wang YG. Yang SQ, et al. Among authors: liao dy. J Drug Target. 2024 Aug;32(7):785-793. doi: 10.1080/1061186X.2024.2353363. Epub 2024 May 14. J Drug Target. 2024. PMID: 38721679 Review.

2

Immune checkpoint inhibitors for RET fusion non-small cell lung cancer: hopes and challenges.

Zhao L, Zhang J, Wang N, Zhang D, Wang Z, Yu Y, Mei Q, Liao D, Jia Y, Kong F. Zhao L, et al. Anticancer Drugs. 2023 Oct 1;34(9):979-984. doi: 10.1097/CAD.0000000000001483. Epub 2022 Dec 19. Anticancer Drugs. 2023. PMID: 36729098

3

Maintenance anlotinib improves the survival prognosis of extensive-stage small cell lung cancer: a single-arm, prospective, phase II study.

Kong F, Wang Z, Wang N, Zhang D, Liao D, Zhang J, Sun Y, Zhang H, Jia Y. Kong F, et al. Am J Cancer Res. 2023 Aug 15;13(8):3679-3685. eCollection 2023. Am J Cancer Res. 2023. PMID: 37693149 Free PMC article.

4

Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review.

Wang J, Liao D, Zhang X, Miao C, Chen K. Wang J, et al. Breast Cancer (Dove Med Press). 2023 Apr 21;15:281-294. doi: 10.2147/BCTT.S407181. eCollection 2023. Breast Cancer (Dove Med Press). 2023. PMID: 37113514 Free PMC article. Review.

5

Non-Small Cell Lung Cancer: Challenge and Improvement of Immune Drug Resistance.

Kong F, Wang Z, Liao D, Zuo J, Xie H, Li X, Jia Y. Kong F, et al. Front Oncol. 2021 Aug 31;11:739191. doi: 10.3389/fonc.2021.739191. eCollection 2021. Front Oncol. 2021. PMID: 34532293 Free PMC article. Review.

6

Traditional Chinese medicines for non-small cell lung cancer: Therapies and mechanisms.

Kong F, Wang C, Zhao L, Liao D, Wang X, Sun B, Yang P, Jia Y. Kong F, et al. Chin Herb Med. 2023 Sep 21;15(4):509-515. doi: 10.1016/j.chmed.2023.05.004. eCollection 2023 Oct. Chin Herb Med. 2023. PMID: 38094015 Free PMC article. Review.

7

Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma.

Sun Y, Ma Q, Chen Y, Liao D, Kong F. Sun Y, et al. Clin Respir J. 2024 May;18(5):e13755. doi: 10.1111/crj.13755. Clin Respir J. 2024. PMID: 38757752 Free PMC article.

8

Advances in Antibody-Drug Conjugates in the Treatment of HER2-Positive Breast Cancer.

Yu Y, Wang J, Liao D, Zhang D, Li X, Jia Y, Kong F. Yu Y, et al. Breast Cancer (Dove Med Press). 2022 Dec 9;14:417-432. doi: 10.2147/BCTT.S384830. eCollection 2022. Breast Cancer (Dove Med Press). 2022. PMID: 36532256 Free PMC article. Review.

9

Advances in Immunotherapy of Malignant Pleural Mesothelioma.

Liao D, Yu Y, Mei Q, Wang Z, Li X, Jia Y, Kong F. Liao D, et al. Onco Targets Ther. 2021 Aug 14;14:4477-4484. doi: 10.2147/OTT.S317434. eCollection 2021. Onco Targets Ther. 2021. PMID: 34429612 Free PMC article. Review.

10

Research Progress of Antibody-Drug Conjugate Therapy for Advanced Gastric Cancer.

Wang N, Mei Q, Wang Z, Zhao L, Zhang D, Liao D, Zuo J, Xie H, Jia Y, Kong F. Wang N, et al. Front Oncol. 2022 May 26;12:889017. doi: 10.3389/fonc.2022.889017. eCollection 2022. Front Oncol. 2022. PMID: 35692796 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters